Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Henry

Showing results (21-30 of 265) with videos related to

Pageof 27
Sort By:
BMJ (Clinical Research Ed.)|May 29, 2004
The free trade agreement between Australia and the United StatesPeter Drahos, David Henry
Gastroenterology|January 31, 2007
Selective COX-2 inhibitors: a promise unfulfilled?David Henry, Patricia McGettigan
Lancet (London, England)|November 22, 2002
The pharmaceutical industry as a medicines providerDavid Henry, Joel Lexchin
Lancet (London, England)|March 28, 2003
Patent lawDavid Henry, Joel Lexchin
ACP Journal Club|March 5, 2003
Upper gastrointestinal event risk with COX-2 inhibitors depended on known risk factorsDavid Henry, Patricia McGettigan
Seminars in Oncology|April 29, 2014
Pharmacoeconomics of cancer therapies: considerations with the introduction of biosimilarsDavid Henry, Carrie Taylor
Plos Medicine|September 17, 2014
WHO essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveysKathleen Anne Holloway, David Henry
Revista Brasileira De Anestesiologia|May 28, 2009
[Anesthesia in pregnant patient with intracranial hypertension due to tuberculous meningitis: case report.]Vanessa Breitenbach, David Henry Wilson
Pharmacoepidemiology and Drug Safety|September 24, 2004
Misleading drug promotion--no sign of improvementsPeter R Mansfield, David Henry
Health Policy (Amsterdam, Netherlands)|March 1, 2025
Identifying the most effective policies for minimising inappropriate use of antibiotics: A replicability study using three WHO datasetsKathleen A Holloway, David Henry
Pageof 27

Showing results (21-30 of 265) with videos related to

Sort By:
Pageof 27
BMJ (Clinical Research Ed.)|May 29, 2004
The free trade agreement between Australia and the United StatesPeter Drahos, David Henry
Gastroenterology|January 31, 2007
Selective COX-2 inhibitors: a promise unfulfilled?David Henry, Patricia McGettigan
Lancet (London, England)|November 22, 2002
The pharmaceutical industry as a medicines providerDavid Henry, Joel Lexchin
Lancet (London, England)|March 28, 2003
Patent lawDavid Henry, Joel Lexchin
ACP Journal Club|March 5, 2003
Upper gastrointestinal event risk with COX-2 inhibitors depended on known risk factorsDavid Henry, Patricia McGettigan
Seminars in Oncology|April 29, 2014
Pharmacoeconomics of cancer therapies: considerations with the introduction of biosimilarsDavid Henry, Carrie Taylor
Plos Medicine|September 17, 2014
WHO essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveysKathleen Anne Holloway, David Henry
Revista Brasileira De Anestesiologia|May 28, 2009
[Anesthesia in pregnant patient with intracranial hypertension due to tuberculous meningitis: case report.]Vanessa Breitenbach, David Henry Wilson
Pharmacoepidemiology and Drug Safety|September 24, 2004
Misleading drug promotion--no sign of improvementsPeter R Mansfield, David Henry
Health Policy (Amsterdam, Netherlands)|March 1, 2025
Identifying the most effective policies for minimising inappropriate use of antibiotics: A replicability study using three WHO datasetsKathleen A Holloway, David Henry
Pageof 27